CN104379143A - 抗癌剂 - Google Patents

抗癌剂 Download PDF

Info

Publication number
CN104379143A
CN104379143A CN201380016479.1A CN201380016479A CN104379143A CN 104379143 A CN104379143 A CN 104379143A CN 201380016479 A CN201380016479 A CN 201380016479A CN 104379143 A CN104379143 A CN 104379143A
Authority
CN
China
Prior art keywords
arctigenin
arctiin
extract
arctium
burdock
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380016479.1A
Other languages
English (en)
Chinese (zh)
Inventor
江角浩安
池田公史
三好千香
门田重利
大洼敏树
与茂田敏
布施贵史
川岛孝则
千叶殖干
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JAPAN GOVERNMENT
Kracie Pharma Ltd
University of Toyama NUC
Original Assignee
JAPAN GOVERNMENT
Kracie Pharma Ltd
University of Toyama NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JAPAN GOVERNMENT, Kracie Pharma Ltd, University of Toyama NUC filed Critical JAPAN GOVERNMENT
Publication of CN104379143A publication Critical patent/CN104379143A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN201380016479.1A 2012-03-26 2013-03-26 抗癌剂 Pending CN104379143A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-069964 2012-03-26
JP2012069964 2012-03-26
PCT/JP2013/058692 WO2013146734A1 (ja) 2012-03-26 2013-03-26 抗癌剤

Publications (1)

Publication Number Publication Date
CN104379143A true CN104379143A (zh) 2015-02-25

Family

ID=49259985

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380016479.1A Pending CN104379143A (zh) 2012-03-26 2013-03-26 抗癌剂

Country Status (8)

Country Link
US (1) US9700572B2 (enExample)
EP (1) EP2832355A4 (enExample)
JP (1) JP5707534B2 (enExample)
KR (1) KR20140139073A (enExample)
CN (1) CN104379143A (enExample)
HK (1) HK1203811A1 (enExample)
IN (1) IN2014MN01973A (enExample)
WO (1) WO2013146734A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109045010A (zh) * 2018-09-19 2018-12-21 淮海工学院 一种具有抗肿瘤作用的药物组合物及其应用

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5696191B2 (ja) * 2013-04-27 2015-04-08 クラシエ製薬株式会社 抗癌幹細胞剤
JP2016079163A (ja) * 2014-10-14 2016-05-16 医療環境テクノ株式会社 腫瘍を処置するための組成物およびその製造方法
JP6773665B2 (ja) * 2015-10-09 2020-10-21 クラシエ製薬株式会社 血管壁強化剤、血管壁を強化する方法および血管網形成抑制剤
JP6876502B2 (ja) * 2016-04-25 2021-05-26 クラシエホールディングス株式会社 未分化細胞除去剤
CN105832719B (zh) * 2016-04-28 2019-05-03 上海中医药大学附属龙华医院 牛蒡苷元在调节pp2a活性中的应用
US11412028B2 (en) 2019-02-08 2022-08-09 Bluepipes, Inc. Online platform and a method for facilitating sharing of data between users
JP7526562B2 (ja) * 2019-11-21 2024-08-01 クラシエ株式会社 レンギョウ葉の加工方法および加工レンギョウ葉

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102365092A (zh) * 2009-03-27 2012-02-29 客乐谐制药株式会社 牛蒡子苷元含量高的牛蒡子提取物及其制造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002065298A (ja) 2000-08-30 2002-03-05 Japan Science & Technology Corp 薬剤成分のスクリーニング方法
CN101036644A (zh) * 2006-03-13 2007-09-19 海南盛科天然药物研究院有限公司 含牛蒡子苷元的药用组合物及其制备方法
KR20080107794A (ko) * 2007-06-08 2008-12-11 경남대학교 산학협력단 우방자 추출물을 함유하는 항암 조성물
KR101538450B1 (ko) 2010-09-27 2015-07-22 구라시에제약 주식회사 악티게닌 함유 우방자 추출물 및 그 제조방법
CN102440986B (zh) * 2010-10-08 2014-12-03 鲁南制药集团股份有限公司 牛蒡子苷元在制备防治辐射或化学品引起的骨髓抑制的药物中的用途

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102365092A (zh) * 2009-03-27 2012-02-29 客乐谐制药株式会社 牛蒡子苷元含量高的牛蒡子提取物及其制造方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109045010A (zh) * 2018-09-19 2018-12-21 淮海工学院 一种具有抗肿瘤作用的药物组合物及其应用
CN109045010B (zh) * 2018-09-19 2021-03-30 淮海工学院 一种具有抗肿瘤作用的药物组合物及其应用

Also Published As

Publication number Publication date
HK1203811A1 (en) 2015-11-06
IN2014MN01973A (enExample) 2015-07-10
WO2013146734A1 (ja) 2013-10-03
US20150196576A1 (en) 2015-07-16
JPWO2013146734A1 (ja) 2015-12-14
US9700572B2 (en) 2017-07-11
JP5707534B2 (ja) 2015-04-30
EP2832355A1 (en) 2015-02-04
KR20140139073A (ko) 2014-12-04
EP2832355A4 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
CN104379143A (zh) 抗癌剂
KR101829637B1 (ko) 참옻나무 목심 추출물을 함유하는 항암치료 부작용에 따른 소화기능장애, 백혈구 감소증 및 골수부전증의 개선, 예방 또는 치료용 조성물
WO2015192758A1 (zh) 瓦草五环三萜皂苷类化合物抗肿瘤的药物用途
JP5696191B2 (ja) 抗癌幹細胞剤
CN114886945A (zh) 一种调节嘌呤代谢的超分子系统及其应用
CN109674866A (zh) 一种抗胃肠癌药物组合物、制备方法及其应用
CN111467358B (zh) 包含人参皂苷Rh3、PPD和Rh2的药物组合物
JP6234553B2 (ja) 抗癌剤および副作用軽減剤
TWI542347B (zh) The use of arctigenin for the preparation of anticancer agents
CN102858359B (zh) 一种含有醇溶性且非水溶性甘草提取物的药物组合物,及其药物制剂、制药用途、治疗方法和制备方法
CN107137416B (zh) 一种防治非小细胞肺癌的药物组合物
CN109731019A (zh) 一种具有化疗增效作用的组合物，包括其的药物、制备方法及应用
CN102477039B (zh) 瓜馥木内酰胺碱化合物的制备方法及其在制备抗肿瘤药物中的应用
TW202206090A (zh) 黃耆醫藥組合物用於增強癌症治療之用途
CN110279730A (zh) 一种冰川茶藨子提取物及其在制备降低餐后血糖药物中的应用
CN110585287A (zh) 胆木提取物在制备抗肿瘤药物中的应用
CN110538231A (zh) 槐花散提取物及其制备和应用
KR20180135845A (ko) 황칠나무 유래 나노입자를 포함하는 암 예방 또는 치료용 약학적 조성물
CN102824398B (zh) 紫景天在制备治疗肿瘤药物中的应用
CN101690738A (zh) 牛筋果及其提取物在制备抗肿瘤药物中的新用途
CN109602775B (zh) 乳苣醇提物在制备抗乳腺癌药物中的用途
CN101505777B (zh) 含有来自金合欢属树皮的物质的肿瘤的预防和/或治疗用组合物
KR20180116904A (ko) 황칠나무 유래 나노입자를 포함하는 암 예방 또는 치료용 약학적 조성물
CN107281400B (zh) 荻的新用途及一种抗肿瘤药物
CN106581027B (zh) 一种化合物及其药物用途、组合物与制剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1203811

Country of ref document: HK

CB02 Change of applicant information

Address after: Tokyo, Japan, Japan

Applicant after: Kracie Pharma, Ltd.

Applicant after: NATIONAL CANCER CENTER

Applicant after: National University Corporation University of Toyama

Address before: Tokyo, Japan, Japan

Applicant before: Kracie Pharma, Ltd.

Applicant before: Japan Government

Applicant before: National University Corporation University of Toyama

CB02 Change of applicant information
RJ01 Rejection of invention patent application after publication

Application publication date: 20150225

RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1203811

Country of ref document: HK